Rise Nano Optics Ltd. logo

Rise Nano Optics Ltd. (U9Y)

Market Closed
16 Oct, 08:00 PM
XFRA XFRA
€
0. 25
+0
+0.3968%
€
8.64M Market Cap
- P/E Ratio
- Div Yield
3,200 Volume
- Eps
€ 0.25
Previous Close
Add Transaction
Day Range
0.25 0.25
Year Range
0.12 0.44
Want to track U9Y and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

U9Y closed today higher at €0.25, an increase of 0.3968% from yesterday's close, completing a monthly increase of 1.6064% or €0. Over the past 12 months, U9Y stock lost -32.3529%.
U9Y is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

U9Y Chart

People also search for

W55
Nutun Limited
€ 0.04
0%
0MU
MailUp S.p.A.
€ 1.72
-5.2486%
UM3
UMC Electronics Co., Ltd.
€ 1.07
-0.9259%
B7Z
Arribatec Group ASA
€ 0.5
-4.1985%
Q58
Secure Inc.
€ 6.9
+0.7299%

Rise Nano Optics Ltd. (U9Y) FAQ

What is the stock price today?

The current price is €0.25.

On which exchange is it traded?

Rise Nano Optics Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is U9Y.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 8.64M.

Has Rise Nano Optics Ltd. ever had a stock split?

No, there has never been a stock split.

Rise Nano Optics Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Inas Said Ph.D. CEO
XFRA Exchange
- ISIN
Israel Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Rise Nano Optics Ltd. is a pioneering health technology company based in Vancouver, British Columbia, dedicated to advancing vision care through innovative nanotechnology lens solutions. The company specializes in the selective filtering of high-energy visible light wavelengths, employing its patented SPECTRAGUARD™ technology. This cutting-edge approach integrates nanomaterial innovation, comprehensive ophthalmic research, and scalable optical engineering to enhance visual comfort while protecting eye health.

Each lens is designed to block 100% of harmful ultraviolet light and up to 90% of intense visible light wavelengths between 400-600 nm, including the known harmful blue light. Notably, these lenses help maintain natural visual clarity and color perception, thereby reducing vision stress, particularly for patients suffering from diabetes-related eye conditions such as cataracts and retinopathy. The company's FDA Class I exempt medical device classification allows for safe use in various clinical applications. In addition to its focus on patient care, Rise Nano Optics also aims to make a significant impact on the broader consumer eyewear market, offering solutions that provide comprehensive light protection while ensuring vision remains unoverly darkened.

Products and Services

  • SPECTRAGUARD™ Lenses

    These advanced lenses utilize proprietary nanotechnology to effectively block 100% of ultraviolet light and up to 90% of intense light within the 400-600 nm wavelength range. Designed for both clinical and everyday use, these lenses help minimize harmful light exposure while preserving natural visual clarity.

  • Clinical Solutions

    Targeted towards eye health professionals, Rise Nano Optics offers clinical solutions specifically for patients with diabetic eye conditions. These lenses help to alleviate vision stress from intense sunlight, improving overall comfort and quality of life for individuals suffering from ailments such as cataracts and retinopathy.

  • Consumer Eyewear

    In addition to its clinical applications, the company provides consumer eyewear options designed for everyday use. These products ensure users benefit from enhanced light protection without sacrificing visual clarity, catering to consumers who are increasingly concerned about eye health in the presence of harmful blue light exposure.

  • Research and Development

    Rise Nano Optics is committed to ongoing research and development to continuously improve its technology and product offerings. By investing in innovation, the company aims to stay at the forefront of advancements in nanotechnology and optics, ultimately enhancing its product efficacy and consumer benefits.

Contact Information

Address: 3A Habishop Hajar
Phone: -